SCHEMBL13543501

SCHEMBL13543501

O=C(O)c1ccc(Cl)c(S(=O)(=O)NCC(F)(F)F)c1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 4/20 0.57
▸ L3MBTL1 Q9Y468 3/20 0.57
▸ TDP1 Q9NUW8 3/20 0.57
▸ HSD17B10 Q99714 1/20 0.53
▸ KDM4E B2RXH2 2/20 0.52
▸ HTT P42858 1/20 0.51
▸ KMT2A Q03164 3/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ MAPK1 P28482 1/20 0.49
▸ MEN1 O00255 2/20 0.48
▸ PIK3CD O00329 1/20 0.47
▸ PIK3CA P42336 1/20 0.47
▸ PIK3CB P42338 1/20 0.47
▸ PIK3CG P48736 1/20 0.47
▸ ERAP1 Q9NZ08 1/20 0.47
▸ GPR55 Q9Y2T6 1/20 0.47
▸ MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13543314 0.86 PIK3CD (0.48) POLBL3MBTL1TDP1HSD17B10KDM4E
SCHEMBL13543493 0.84 PTK2B (0.58) POLBL3MBTL1TDP1HTTSMN1; SMN2
SCHEMBL9436722 0.79 POLB (0.58) POLBL3MBTL1TDP1HSD17B10KDM4E
SCHEMBL11710429 0.78 POLB (0.57) POLBL3MBTL1TDP1HSD17B10KDM4E
SCHEMBL18723228 0.78 POLB (0.75) POLBL3MBTL1TDP1HSD17B10HTT
SCHEMBL8067660 0.77 POLB (0.62) POLBL3MBTL1TDP1HSD17B10KDM4E
SCHEMBL13544479 0.77 ATM (0.51) POLBTDP1HSD17B10KMT2AMEN1
SCHEMBL11595503 0.77 POLB (0.56) POLBL3MBTL1TDP1HSD17B10KDM4E
SCHEMBL11595561 0.77 POLB (0.62) POLBL3MBTL1TDP1HSD17B10KDM4E
SCHEMBL1018953 0.76 MEP1B (0.58) L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7645771-B2 CCR5 antagonists as therapeutic agents SMITHKLINE BEECHAM CORP. (US) 2010-01-12 — — US disclosed
US-7645771-B2 CCR5 antagonists as therapeutic agents SMITHKLINE BEECHAM CORP. (US) 2010-01-12 — — US disclosed
Send feedback